ABI3BP
Target of Nesh-SH3
Also known as: DKFZP586L2024, NESHBP, TARSH, TARSH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z7G0
- Gene
- ABI3BP
- Ensembl
- ENSG00000154175
- Chromosome
- 3
- Canonical length
- 1068 aa
- Protein class
- Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to enable actin filament binding activity. Predicted to be involved in several processes, including extracellular matrix organization; positive regulation of cell-substrate adhesion; and regulation of postsynapse organization. Located in collagen-containing extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
1068 residues, UniProt reviewed canonical sequence.
>Q7Z7G0|ABI3BP
1 MLSSLGCLLL CGSITLALGN AQKLPKGKRP NLKVHINTTS DSILLKFLRP SPNVKLEGLL
61 LGYGSNVSPN QYFPLPAEGK FTEAIVDAEP KYLIVVRPAP PPSQKKSCSG KTRSRKPLQL
121 VVGTLTPSSV FLSWGFLINP HHDWTLPSHC PNDRFYTIRY REKDKEKKWI FQICPATETI
181 VENLKPNTVY EFGVKDNVEG GIWSKIFNHK TVVGSKKVNG KIQSTYDQDH TVPAYVPRKL
241 IPITIIKQVI QNVTHKDSAK SPEKAPLGGV ILVHLIIPGL NETTVKLPAS LMFEISDALK
301 TQLAKNETLA LPAESKTPEV EKISARPTTV TPETVPRSTK PTTSSALDVS ETTLASSEKP
361 WIVPTAKISE DSKVLQPQTA TYDVFSSPTT SDEPEISDSY TATSDRILDS IPPKTSRTLE
421 QPRATLAPSE TPFVPQKLEI FTSPEMQPTT PAPQQTTSIP STPKRRPRPK PPRTKPERTT
481 SAGTITPKIS KSPEPTWTTP APGKTQFISL KPKIPLSPEV THTKPAPKQT PRAPPKPKTS
541 PRPRIPQTQP VPKVPQRVTA KPKTSPSPEV SYTTPAPKDV LLPHKPYPEV SQSEPAPLET
601 RGIPFIPMIS PSPSQEELQT TLEETDQSTQ EPFTTKIPRT TELAKTTQAP HRFYTTVRPR
661 TSDKPHIRPG VKQAPRPSGA DRNVSVDSTH PTKKPGTRRP PLPPRPTHPR RKPLPPNNVT
721 GKPGSAGIIS SGPITTPPLR STPRPTGTPL ERIETDIKQP TVPASGEELE NITDFSSSPT
781 RETDPLGKPR FKGPHVRYIQ KPDNSPCSIT DSVKRFPKEE ATEGNATSPP QNPPTNLTVV
841 TVEGCPSFVI LDWEKPLNDT VTEYEVISRE NGSFSGKNKS IQMTNQTFST VENLKPNTSY
901 EFQVKPKNPL GEGPVSNTVA FSTESADPRV SEPVSAGRDA IWTERPFNSD SYSECKGKQY
961 VKRTWYKKFV GVQLCNSLRY KIYLSDSLTG KFYNIGDQRG HGEDHCQFVD SFLDGRTGQQ
1021 LTSDQLPIKE GYFRAVRQEP VQFGEIGGHT QINYVQWYEC GTTIPGKWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABI3BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- gallbladder: 92 nTPM
- urinary bladder: 90 nTPM
- ovary: 73 nTPM
- smooth muscle: 67 nTPM
- lung: 65 nTPM
- blood vessel: 59 nTPM
Single-cell type
- fibro-adipogenic progenitors: 732 nCPM
- fibroblasts: 488 nCPM
- müller glia: 396 nCPM
- cardiomyocytes: 372 nCPM
- leydig cells: 364 nCPM
- epicardial cells: 343 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 64 nTPM
- basal ganglia: 27 nTPM
- white matter: 25 nTPM
- medulla oblongata: 22 nTPM
- midbrain: 19 nTPM
- spinal cord: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.83
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ABI3BP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABI3BP as an antibody target. Whether an autoantibody or antibody against ABI3BP could matter depends on whether native ABI3BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABI3BP is annotated as secreted, so native ABI3BP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ABI3BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...